CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.

Chen, Chen; Wang, Zehua; Qin, Yanru

Chen, Chen; Wang, Zehua; Qin, Yanru.

Afiliação

Chen C; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qin Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yanruqin@163.com.

Exp Hematol Oncol ; 12(1): 95, 2023 Nov 14.

Article em En | MEDLINE | ID: mdl-37964355

Palavras-chave

Adoptive cell therapy; CRISPR/Cas9; Cancer immunotherapy; Gene editing; Target discovery

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google